Delivery Order SPE2DB20D3101-SPE2DB24FRSL6
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,930.74 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 3, 2024 and was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,371.23 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024. The contract has a period of performance through June 26, 2024 and does not have any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,466.13 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 3, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $17,732.40 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 21, 2023. The contract has an ultimate completion date of September 22, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $4,523.36 and is a firm fixed-price delivery order that runs through June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $5,102.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award from the Defense Logistics Agency (DLA) is for the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The $5,377.92 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of June 21, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,711.46, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of July 1, 2024. Amerisourcebergen Drug Corp, through its...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,308.79 and is a firm-fixed-price delivery order with an ultimate completion date of July 22, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,715.72 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical and medical supplies to the U.S. government. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...